Researcher at Asahikawa Medical University Publishes New Study Findings on Neurogenic Bladder (Diagnosis and Treatment of Japanese Children with Neurogenic Bladder: Analysis of Data from a National Health Insurance Database): Neurogenic Bladder

2023 MAY 12 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily -- Investigators discuss new findings in neurogenic bladder. According to news originating from Asahikawa Medical University by NewsRx editors, the research stated, “In pediatric patients with neurogenic bladder (NGB), urinary tract evaluation, early diagnosis, and individualized management are important. We aimed to clarify the current status of diagnosis and treatment of NGB in Japanese children.”

Financial supporters for this research include Pfizer Japan Inc..

Our news journalists obtained a quote from the research from Asahikawa Medical University: “This descriptive, observational, retrospective cohort study using the JMDC claims database included NGB patients aged 17 years over a 12-month follow-up period. Of the 1065 pediatric NGB patients, 38.9% had spina bifida. Dermatological and gastrointestinal comorbidities were common in the baseline period. Renal/bladder ultrasound was a commonly performed investigation (38.3%), but urodynamics was infrequently used (3.0%). Of all the overactive bladder medications, anticholinergics were used commonly (17.9% patients), and most patients used anticholinergics alone (without combination therapy). Clean intermittent catheterization (CIC; alone or in combination with medications) was performed in 9.3% of patients, and 3.9% of patients were concomitantly treated with medications.”

According to the news reporters, the research concluded: “The most common incident complication was lower urinary tract infection (18.1%), which was especially common in patients with open spina bifida (54.1%). Despite guideline recommendations, lower urinary tract dysfunction is not thoroughly evaluated. Adequate understanding of patient status is critical to optimal patient management (behavioral therapy, CIC, and medication) in clinical practice.”

For more information on this research see: Diagnosis and Treatment of Japanese Children with Neurogenic Bladder: Analysis of Data from a National Health Insurance Database. Journal of Clinical Medicine, 2023,12(9). (Journal of Clinical Medicine - http://www.mdpi.com/journal/jcm). The publisher for Journal of Clinical Medicine is MDPI AG.

A free version of this journal article is available at https://doi.org/10.3390/jcm12093191.

Our news editors report that additional information may be obtained by contacting Takeya Kitta, Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa City 078-8510, Japan. Additional authors for this research include Takahiko Mitsui, Naoko Izumi.

ORCID is an identifier for authors and includes bibliographic information. The following is ORCID information for the authors of this research: Takeya Kitta (http://orcid.org/0000-0003-2870-9225), Takahiko Mitsui (http://orcid.org/0000-0003-0408-3678), Naoko Izumi (http://orcid.org/0000-0001-5135-2987).

(Our reports deliver fact-based news of research and discoveries from around the world.)